comparemela.com
Home
Live Updates
Data From 2023 ASH Annual Meeting Provide Positive Updates in Multiple Myeloma : comparemela.com
Data From 2023 ASH Annual Meeting Provide Positive Updates in Multiple Myeloma
Experts discuss treatment in newly diagnosed multiple myeloma and the role of CAR T-cell therapies and bispecifics in relapsed/refractory disease.
Related Keywords
California ,
United States ,
Illinois ,
San Diego ,
Chicago ,
American ,
Caitlin Costello ,
Krinak Patel ,
American Society Of Clinical Oncology Annual Meeting ,
Onclive Peer Exchange ,
American Society Of Hematology Annual Meeting Exposition ,
American Society ,
Hematology Annual Meeting ,
Newly Diagnosed Multiple ,
Cell Therapy ,
Refractory Multiple ,
Clinical Oncology Annual Meeting ,
Cart Cell Therapies ,
Bispecifics In Relapsed Refractory Disease ,
Newly Diagnosed Multiple Myeloma ,
comparemela.com © 2020. All Rights Reserved.